
Zydus Wellness Q4 FY26 Results: PAT Rs 162 Cr, Revenue Rs 1,485 Crore
Updated: 19 May 2026 • 6:00 pm
Posted by:

Click Here – Get Free Investment Predictions
Zydus Wellness Q4 FY26 Financial Highlights
| Metric | Q4 FY26 | Comparison |
|---|---|---|
| PAT (Net Profit) | Rs 162 crore | down 5.8% YoY from Rs 172 crore in Q4 FY25 |
| Revenue from Operations | Rs 1,485 crore | Quarter ended March 31, 2026 |
| Ticker | Sector: FMCG |
Zydus Wellness Q4 FY26 Performance Analysis
Zydus Wellness Q4 FY26 reflects the company’s operational performance during the January to March 2026 quarter. Zydus Wellness is a leading consumer health and wellness products company whose Q4 FY26 print sets the baseline for FY27 guidance. The profitability improvement demonstrates effective operating leverage and cost management. Q4 January to March is typically a seasonally strong quarter for Indian companies, driven by year-end government procurement and project completion cycles.
Investors tracking Zydus will monitor FY27 revenue guidance, margin trajectory, and management commentary. Track Zydus Wellness on the Univest Screener for live data.
Check the Univest Screener for live data
Key Factors for the Company
Revenue and Sector Dynamics
Zydus revenue of Rs 1,485 crore reflects the company’s execution in the consumer health and wellness products space. India’s sustained economic growth of 6.5%+ and robust domestic demand across sectors provide a supportive backdrop for FY27 business planning.
Profitability and Margin Trends
The company PAT of Rs 162 crore, down 5.8% YoY from Rs 172 crore in Q4 FY25, demonstrates consistent earnings delivery and improving profitability metrics. Management commentary on FY27 capex and growth investments will guide the stock’s near-term trajectory.
FY27 Business Outlook
Following the firm results, management guidance on FY27 revenue, order book, and strategic priorities will be key catalysts. Download the Univest iOS App or Univest Android App to receive SEBI-registered analyst research on Zydus Wellness.
Frequently Asked Questions on Zydus
What is the company’s PAT?
Ans. Zydus reported PAT of Rs 162 crore, down 5.8% YoY from Rs 172 crore in Q4 FY25. Results declared May 18, 2026. Full details from NSE/BSE regulatory filings. Verify all data before investing.
What is the company’s revenue?
Ans. The firm’s revenue from operations was Rs 1,485 crore for the quarter ended March 31, 2026. Track live on the Univest Screener.
When were Zydus results announced?
Ans. The company results were announced on May 18, 2026, at the board meeting approving audited Q4 and FY26 financial statements for the year ended March 31, 2026.
Is Zydus Wellness a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, sector dynamics, and personal risk tolerance. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
Kiaasa Retail Q4 FY26 Results: PAT Rs 17 Cr, Revenue Rs 249 Crore
Xchanging Solutions Analyst Review May 2026
Kilitch Drugs (India) Q4 FY26 Results: PAT Rs 15 Cr, Revenue Rs 90 Crore
Emcure Pharmaceuticals Analyst Review May 2026
Popular this week
Kiaasa Retail Q4 FY26 Results: PAT Rs 17 Cr, Revenue Rs 249 Crore
Xchanging Solutions Analyst Review May 2026
Kilitch Drugs (India) Q4 FY26 Results: PAT Rs 15 Cr, Revenue Rs 90 Crore
Emcure Pharmaceuticals Analyst Review May 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
